Skip to content
← Home

Atlas Guide

What is ME/CFS?

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome is a chronic, multi-system disease defined by its hallmark feature: post-exertional malaise.

Quick read · 30 sec

ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) is a chronic, multi-system disease. Its hallmark is post-exertional malaise (PEM) — a worsening of symptoms after physical, cognitive, or emotional exertion.

  • Affects an estimated 15–30 million people worldwide
  • Not explained by other medical conditions
  • Not caused by deconditioning or lack of exercise
  • Not a psychiatric condition
  • Involves measurable biological abnormalities
  • No approved cure currently exists

Key statistics

  • Estimated prevalence: 0.4–1% of the population
  • Women affected 2–4 times more often than men
  • Can affect any age, including children
  • Average time to diagnosis: 5+ years in many countries
  • ~25% of patients are housebound or bedbound
  • Significant overlap with Long COVID — a substantial subset of Long COVID patients may meet ME/CFS criteria (estimates vary across studies)

Standard · 3 min

Core Features

Post-exertional malaise (PEM)

PEM is the hallmark of ME/CFS — a worsening of symptoms following physical, cognitive, or emotional exertion, often delayed by 12–72 hours and disproportionate to the effort involved. Rest does not reliably resolve it. PEM is required for diagnosis under the Canadian Consensus Criteria, International Consensus Criteria, and IOM 2015 guidelines.

What is PEM? → · Full guide to PEM →

Unrefreshing sleep

People with ME/CFS typically wake feeling unrefreshed regardless of sleep duration. Sleep studies have documented abnormalities in sleep architecture, including disrupted slow-wave sleep and altered autonomic function during sleep. The relationship between sleep disruption and other ME/CFS symptoms remains an active area of research.

Cognitive dysfunction

Commonly described as “brain fog,” cognitive dysfunction in ME/CFS includes difficulty with memory, concentration, word retrieval, and processing speed. Research suggests reduced cerebral blood flow may contribute, particularly during orthostatic stress. Cognitive exertion can also trigger PEM — reading, screen time, or focused conversation can cause symptom worsening delayed by hours or days.

Orthostatic intolerance

Many people with ME/CFS experience worsening symptoms when upright — standing, sitting, or walking — due to abnormal autonomic nervous system responses. Forms include postural orthostatic tachycardia syndrome (POTS), neurally mediated hypotension (NMH), and reduced cerebral blood flow. Tilt table testing can objectively demonstrate these abnormalities. Orthostatic intolerance is one of the most consistently reported objective findings in ME/CFS.

Triggers and Onset

Infection-triggered onset

Infection is the most commonly reported trigger for ME/CFS. Viral infections — including Epstein-Barr virus (EBV), enteroviruses, and SARS-CoV-2 — are most frequently implicated, though bacterial and other infections have also been reported. Not all infections lead to ME/CFS; individual vulnerability factors that determine who develops chronic illness after infection remain an active area of research.

Gradual onset

Some patients report a slow decline in function without a clear triggering event. Symptoms may emerge incrementally over weeks, months, or longer, making onset difficult to pinpoint. Whether gradual-onset ME/CFS involves the same underlying mechanisms as post-infectious onset is not yet established.

Other triggers

Surgery, physical trauma, severe stress events, and — in rare reports — vaccination have been described as triggers in some patients. The role of these triggers remains poorly understood, and it is unclear whether they initiate the same disease process as infection-triggered onset or represent distinct pathways.

Long COVID connection

A significant subset of people with Long COVID meet diagnostic criteria for ME/CFS. This overlap has accelerated research funding and public attention toward post-infectious chronic illness.

ME/CFS and Long COVID are not identical. They share core features — post-exertional malaise, cognitive dysfunction, autonomic impairment — but may have distinct mechanisms. Some Long COVID patients experience organ damage not typically seen in ME/CFS, while some ME/CFS features are not universally present in Long COVID. Research on Long COVID overlap →

What ME/CFS is Not

State of the Evidence

What we know

  • Post-exertional malaise is a core distinguishing feature of ME/CFS in modern diagnostic frameworks
  • Reduced cerebral blood flow during orthostatic or tilt testing has been reported in several studies
  • Two-day CPET can show objective post-exertional impairment in a subset of patients
  • Immune abnormalities have been reported across multiple studies, though findings are not uniform across cohorts
  • Metabolic abnormalities have been reported in multiple studies, but no single metabolic signature is yet definitive
  • Reduced NK cell cytotoxicity has been reported in several studies, though findings are not uniform across all cohorts
  • ME/CFS and Long COVID show important areas of biological overlap, though the relationship is still being defined

What remains uncertain

  • Neuroinflammation may be an important mechanism in at least some patients
  • A hypometabolic state may contribute to impaired energy production
  • Autoimmune processes may be involved in a subset of patients
  • Gut microbiome changes may contribute to symptoms or downstream immune effects
  • Viral persistence or reactivation may help maintain illness in some patients
  • Small fiber neuropathy may help explain some sensory and autonomic symptoms

What is emerging

  • What initiates the illness in each individual patient
  • Whether ME/CFS is one disease or several overlapping biological subtypes
  • How to reliably reverse the illness
  • Why severity varies so widely between patients
  • The precise mechanism of post-exertional malaise
  • Whether early intervention can change long-term trajectory
  • The full nature of the overlap and distinction between ME/CFS and Long COVID

Living with ME/CFS

Impact on daily life

Most people with moderate-to-severe ME/CFS cannot work or attend school. Financial hardship is common due to lost income and limited disability recognition in many countries. Many patients depend on family members or partners for daily care.

Social isolation is pervasive. The effort required for social interaction can trigger PEM, leading many patients to withdraw from relationships and community life. The invisible nature of the illness — patients may appear well during brief interactions — compounds misunderstanding from others.

Pacing

Pacing is the most widely recommended self-management strategy for ME/CFS. It involves staying within individual energy limits — sometimes called “the energy envelope” — to reduce the frequency and severity of PEM episodes.

Pacing is not a cure, but a protective strategy. It requires learning to identify personal thresholds for physical, cognitive, and emotional exertion. Some patients use heart rate monitoring to identify objective thresholds, aiming to stay below the anaerobic threshold during daily activities.

What helps, what harms

There is currently no approved pharmacological treatment for ME/CFS. Symptomatic treatments — for sleep disturbance, pain, and orthostatic intolerance — may help some patients manage specific symptoms.

Graded exercise therapy (GET), as traditionally practiced, is no longer recommended by the NICE 2021 guidelines. Research suggests it may worsen symptoms through PEM induction. Cognitive behavioral therapy (CBT) may help some patients cope with the psychological impact of chronic illness but does not treat the underlying disease.

Prognosis

Full recovery from ME/CFS is uncommon, especially in adults. Some patients improve over time; some remain stable; some deteriorate, particularly if repeatedly exposed to PEM triggers.

Early diagnosis and appropriate management — especially learning to avoid PEM triggers through pacing — may improve long-term outcomes. Children and adolescents may have better recovery prospects than adults, though data is limited.

Psychological and social consequences

ME/CFS can produce severe secondary consequences beyond its biological symptoms: grief for lost capacity and identity, social isolation, and — for many patients — significant secondary anxiety or depression.

These are consequences of a biological illness, not evidence of psychological causation. A patient in severe distress because of ME/CFS is not a patient whose illness is explained by that distress. The two facts coexist and require separate accounts.

Diagnostic Criteria

Severity Spectrum


Deep dive · 10+ min

Research History & Context


Related